The average Novartis Oncology Financial Analyst in Boulder earns an estimated $79,730 annually, which includes an estimated base salary of $73,397 with a $6,333 bonus. Novartis Oncology's Financial Analyst compensation is $7,670 less than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Oncology in Boulder can range from $57,500 - $86,000.
In Boulder, The Finance Department at Novartis Oncology earns $4,829 more on average than the Operations Department.
Last updated 3 years ago.
In Boulder, Financial Analysts earn $1,730 more than Business Analysts, and $10,550 less than Senior Accountants.
In Boulder, The Finance Department averages $4,829 more than the Operations Department, and $16,534 less than the Sales Department
The average female Financial Analyst at companies similar size to Novartis Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
The majority of Financial Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Financial Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology